AlphAIalphai — Financial news for AI agents
fool.comAUG 136 min read$ATS

ATS (ATS) Q1 2027 Earnings Call Transcript

ATS Corporation reported Q1 fiscal 2027 results on Aug. 6, 2026. Adjusted revenue was $698 million, down 5% y/y, and adjusted EPS was $0.35. Adjusted earnings from operations fell 13.4% to $68.1 million. Order backlog was $1.9 billion and Q2 revenue guidance was $660 million to $700 million. ATS also outlined an 18-month transformation program and $70m to $90m capex guidance.

Original reporting
fool.com
Published Aug 13, 2026, 7:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 7:18 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
ATS (ATS) Q1 2027 Earnings Call Transcript — source image
Source · fool.com
Decision brief

The 30-second read

$ATSNeutralMed
01

Why it matters

Investors will likely weigh whether Q2 revenue guidance ($660M-$700M) is achievable given lower order bookings and whether radiopharmaceutical backlog can sustain growth beyond GLP-1-related activity.

02

Market read

This is a company-specific earnings and guidance disclosure with quantified transformation savings, backlog mix, and Q2 revenue range that can drive near-term positioning.

03

What to watch

Execution risk over the 18-month timeline, plus restructuring and noncash charges, could delay margin expansion even if gross margin improved early.

Relevance 8/10Novelty 7/10Timing: post-earnings call, ahead of Q2 results window

Background

ATS discussed Q1 FY2027 results, backlog composition, and an 18-month fixed-cost transformation focused on Europe consolidation and higher-margin aftermarket services.

Company-level read

Ticker impact

$ATSNeutralMedium confidence
Context

ATS reported Q1 FY2027 adjusted EPS of $0.35 and guided Q2 revenue to $660M-$700M alongside an 18-month cost transformation plan.

Expected impact

Moderate volatility likely around Q2 guide and margin/cost-savings credibility, with upside if investors buy into service and radiopharma growth.

Evidence & confidence

The article contains concrete earnings metrics, backlog/bookings changes, and explicit Q2 revenue guidance plus a quantified transformation savings framework, which can re-rate near-term expectations.

Market effects

Sector

Highlights demand and margin levers in life sciences services, radiopharmaceuticals, and nuclear-related engineering, potentially informing read-across for automation and regulated-market peers.

Regional

European facility consolidation and transformation savings could shift cost expectations for European operations within the sector.

Global

Backlog composition (life sciences, food and beverage, energy) and radiopharmaceutical emphasis reinforce global capex and isotope production demand narratives.

Counterpoint

What could challenge this read

The revenue decline and lower order bookings suggest the transformation may not fully offset near-term demand lumpiness, making the guide more fragile than it appears.

Key entities

  • company
    ATS Corporation

    Subject of the earnings call transcript, providing Q1 results, Q2 revenue guidance, backlog metrics, and an 18-month transformation plan.

  • executive
    Douglas Wright

    CEO who discussed portfolio review conclusions, backlog growth drivers, and transformation intent.

  • executive
    Michael Anne Cybulski

    Interim CFO who cited margin improvement and transformation objectives.

Read at source← All news

Related articles

AUG 7
$ATSMed

ATS Q1 Earnings Call Highlights

ATS said it will consolidate some European facilities and shift technical capabilities to sites with capacity. Management expects the first phase to deliver about CAD 20 million in annualized savings, about 30% of the total fixed-cost program (CAD 60-70 million). Q1 restructuring costs were CAD 5.7 million and non-cash charges CAD 21.5 million. ATS guided Q2 revenue to CAD 660-700 million.

yahoo.com6 min
AUG 6
$ATSMed

ATS Reports First Quarter Fiscal 2027 Results and Announces a Fixed Cost Transformation Program

ATS Corporation reported fiscal 2027 first-quarter results for the three months ended June 28, 2026. Revenues were C$693.7 million versus C$736.7 million a year earlier, with a C$0.3 million net loss. Adjusted EBITDA was C$92.9 million. ATS also announced an 18-month Fixed Cost Transformation Program, targeting 15% adjusted earnings from operations margin, with an initial European footprint consolidation and expected C$20 million annual cost reductions.

montrealgazette.com6 min
MAY 29
$ATSMedAI 9/10

ATS (ATS) Q4 2026 Earnings Call Transcript

ATS reported Q4 2026 adjusted revenues of $744 million (+3.2%); organic growth was 1.5% with a 1.7% FX benefit. Q4 adjusted earnings from operations rose 3.4% to $76.8 million; gross margin was 29.4%. Order bookings were $704 million (-18.4%) and backlog about $2 billion. Fiscal 2027 guidance calls for Q1 revenues $700–$740 million and modest full-year growth, with margin improving 50–75 bps.

fool.com6 min
MAY 28
$ATSMedAI 9/10

ATS Reports Narrower Q4 Loss Due To Higher Revenues, Stock Up

ATS Corporation reported a narrower Q4 2026 net loss for the quarter ended March 31, 2026, citing higher revenues partly offset by higher SG&A. Net loss fell to C$16.2m (from C$68.9m); loss per share to C$0.16 (from C$0.70). Total revenue rose to C$747.1m (from C$574.2m). Outlook for Q1 2027: revenue C$700m–C$740m. Shares closed at $35.27.

rttnews.com4 min
MAY 28
$ATSMedAI 9/10

ATS Q4 Earnings Call Highlights

ATS (NYSE:ATS) reported fiscal 2026 revenue and adjusted earnings from operations each up about 11%, with Q4 adjusted revenue at CAD 744 million (+3.2%) and adjusted earnings from operations at CAD 76.8 million (+3.4%). Management outlined restructuring to improve margins and cash, including repositioning transportation, expected to remove ~CAD 50 million of dilutive revenue. Q4 order bookings fell 18.4% to CAD 704 million.

dailypolitical.com7 min